MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
  • XML
    92.23 Kb
  • PDF
    201.17 Kb
  • HTML
    64.77 Kb
You must be logged in to use this functionality
Loading full text...

Full text loading...

1. Abernathy, T. J.,, and O. T. Avery. 1941. The occurrence of a protein not normally present in the blood. I. Distribution of the reactive protein in patients’ sera and the effect of calcium on the flocculation reaction with C polysaccharide. J. Exp. Med. 73: 173 182.
2. Austrian, R. 1953. Morphologic variation in pneumococcus. I. An analysis of the bases for morphologic variation in pneumococcus and description of a hitherto undefined morphologic variant. J. Exp. Med. 98: 21 34.
3. Austrian, R. 1977. Of gold and pneumococci. Trans. Am. Clin. Climatol. Assoc. 89: 141 161.
4. Austrian, R. 1960. The Gram stain and the etiology of lobar pneumonia, an historical note. Bacteriol. Rev. 24: 261 265.
5. Austrian, R. 1981. Pneumococcus: the first one hundred years. Rev. Infect. Dis. 3: 183 189.
6. Austrian, R. 1986. Some aspects of the pneumococcal carrier state. J. Antimicrob. Chemother. 18 (Suppl. A): 35 45.
7. Austrian, R.,, R. M. Douglas,, G. Schiffman,, A. M. Coetzee,, H. J. Koornhof,, S. Hayden-Smith,, and R. D. W. Reid. 1976. Prevention of pneumococcal pneumonia by vaccination. Trans. Assoc. Am. Phys. 89: 184 194.
8. Austrian, R.,, and J. Gold. 1964. Pneumococcal bacteremia with a special reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med. 60: 759 776.
9. Avery, O. T.,, H. T. Chickering,, R. Cole,, and A. R. Dochez. 1917. Acute lobar pneumonia. Prevention and treatment. Rockefeller Institute for Medical Research monograph 7, p. 1 100. The Rockfeller Institute for Medical Research, New York, N.Y.
10. Avery, O. T.,, and R. Dubos. 1930. The specific action of a bacterial enzyme on pneumococci of type III. Science 72: 151 152.
11. Avery, O. T.,, and R. Dubos. 1931. The protective action of a specific enzyme against type III pneumococcus infection in mice. J. Exp. Med. 54: 73 89.
12. Avery, O. T.,, and W. F. Goebel. 1931. Chemo-immunological studies on conjugated carbohydrate proteins. V. The immunological specificity of an antigen prepared by combining the capsular polysaccharide of type III pneumococcus with a foreign protein. J. Exp. Med. 54: 437 447.
13. Avery, O. T.,, C. M. MacLeod,, and M. McCarty. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a deoxyribonucleic acid fraction from pneumococcus type 3. J. Exp. Med. 79: 137 158.
14. Bezançon, F.,, and V. Griffin. 1897. Pouvoir agglutinatif du serum dans les infections expérimentales et humaines, à pneumocoques. C. R. Soc. Biol. 48: 579 581.
15. Black, S.,, H. Shinefield,, B. Firman,, E. Lewis,, P. Ray,, J. R. Hansen,, L. Elvin,, K. M. Ensor,, J. Hackell,, G. Siber,, F. Malinoski,, D. Madore,, I. Chang,, R. Kohberger,, W. Watson,, R. Austrian,, K. Edwards, and the Northern California Permanente Vaccine Group. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19: 187 195.
16. Bornstein, D. L.,, G. Schiffman,, H. P. Bernheimer,, and R. Austrian. 1968. Capsulation of pneumococci with soluble C-like (Cs) polysaccharide. J. Exp. Med. 128: 1385 1400.
17. Boulnois, G. J. 1992. Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae. J. Gen. Microbiol. 138: 249 259.
18. Bowers, E. F.,, and L. R. Jeffries. 1955. Optochin in the identification of Str. pneumoniae. J. Clin. Pathol. 8: 58 60.
19. Briles, D. E.,, R. C. Tart,, E. Swiatlo,, J. P. Dillard,, P. Smith,, K. A. Benton,, B. A. Ralph,, A. Brooks-Walter,, M. J. Crain,, S. K. Hollingshead,, and L. S. Mc- Daniel. 1998. Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin. Microbiol. Rev. 11: 645 657.
20. Chargaff, E. 1951. Structure and function of nucleic acids as cell constituents. Fed. Proc. 10: 654 659.
21. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885 891.
22. Cooper, G.,, C. Rosenstein,, A. Walter,, and L. Peizer. 1932. The further separation of types among the types of pneumococci hitherto included in Group IV and the development of therapeutic antisera for these types. J. Exp. Med. 55: 531 554.
23. Davies, J. A. V. 1937. The response of infants to inoculation with type 1 pneumococcus carbohydrate. J. Immunol. 33: 1 7.
24. Dawson, M. H. 1928. Interconvertability of “R” and “S” forms of pneumococcus. J. Exp. Med. 47: 577 591.
25. Dochez, A. R.,, and O. T. Avery. 1917. Soluble substance of pneumococcal origin in the blood and urine during lobar pneumonia. Proc. Soc. Exp. Biol. Med. 14: 126 127.
26. Dochez, A. R.,, and O. T. Avery. 1917. The elaboration of specific soluble substance by pneumococcus during growth. J. Exp. Med. 26: 477 493.
27. Ekwurzel, G. M.,, J. S. Simmons,, L. I. Dublin,, and L. D. Felton. 1938. Studies on immunizing substances in pneumococci. VIII. Report on field tests to determine the prophylactic value of a pneumococcus antigen. Public Health Rep. 53: 1877 1893.
28. Felton, L. D. 1928. The units of protective antibody in antipneumococcus serum and antibody solution. J. Infect. Dis. 43: 531 542.
29. Finland, M.,, and H. F. Dowling. 1935. Cutaneous reactions and antibody response of human subjects to intracutaneous injections of pneumococcus polysaccharides. J. Immunol. 29: 285 299.
30. Finland, M.,, and W. D. Sutliff. 1932. Specific cutaneous reactions and circulating antibodies in the course of lobar pneumonia. I. Cases receiving no serum therapy. J. Exp. Med. 54: 637 652.
31. Fraenkel, A. 1885. Bakteriologische Mittheilungen. Z. Klin. Med. 10: 401 461.
32. Francis, T. J., Jr.,, and W. S. Tillett. 1930. Cutaneous reactions in pneumonia. The development of antibodies following the intradermal injection of type-specific polysaccharides. J. Exp. Med. 52: 573 585.
33. Gamaléia, N. 1888. Sur l’étiologie de la pneumonie fibrineuse chez l’homme. Ann. Inst. Pasteur (Paris) 2: 440 459.
34. Gram, C. 1884. Ueber die isolierte Färbung der Schizomyceten in Schnitt- und Trokenpräparaten. Fortschr. Med. 2: 185 189.
35. Griffith, F. 1928. The significance of pneumococcal types. J. Hyg. 27: 113 159.
36. Gundel, M.,, and F. K. T. Schwarz. 1932. Studien über die Bakterienflora der obern Atmungswege Neugeborner (im Vergleich mit der Mundhöhlenflora der Mutter und des Pflegepersonals) unter besonderer Berüchsichtigung ihrer Bedeutung für das Pneumonieproblem. Z. Hyg. Infektionskr. 113: 411 436.
37. Gundel, M.,, and G. Okura. 1933. Untersuchungen über das gleichzeitige Vorkommen mehrerer Pneumokokkentypen bei Gesunden und ihrer Bedeutung für die Epidemiologie. Z. Hyg. Infektionskr. 114: 678 704.
38. Hansman, D.,, H. Glasgow,, J. Sturt,, L. Devitt,, and R. Douglas. 1971. Increased resistance to penicillin of pneumococci isolated from man. N. Engl. J. Med. 284: 175 177.
39. Harford, C. G.,, and M. Hara. 1950. Pulmonary edema in influenzal pneumonia of the mouse and the relation of fluid in the lung to the inception of pneumococcal pneumonia. J. Exp. Med. 91: 245 259.
40. Hayes, W. 1966. The discovery of pneumococcal type transformation: an appreciation. J. Hyg. 64: 177 184.
41. Heffron, R. 1939. Pneumonia with Special Reference to Pneumococcus Lobar Pneumonia, p. 446 475. The Commonwealth Fund, New York, N.Y.
42. Heffron, R. 1939. Pneumonia with Special Reference to Pneumococcus Lobar Pneumonia, p. 888 903. The Commonwealth Fund, New York, N.Y.
43. Heidelberger, M.,, and O. T. Avery. 1923. The soluble specific substance of the pneumococcus. J. Exp. Med. 38: 73 79.
44. Heidelberger, M.,, and F. E. Kendall. 1929. A quantitative study of the precipitin reaction between type III pneumococcus polysaccharide and purified homologous antibody. J. Exp. Med. 50: 809 823.
45. Heidelberger, M.,, C. M. MacLeod,, S. J. Kaiser,, and B. Robinson. 1946. Antibody formation in volunteers following injection of pneumococci or their typespecific polysaccharides. J. Exp. Med. 83: 303 320.
46. Henrichsen, J. 1995. Six newly recognized types of Streptococcus pneumoniae. J. Clin. Microbiol. 33: 2759 2762.
47. Hodges, R. G.,, C. M. MacLeod,, and W. G. Bernhard. 1946. Epidemic pneumococcal pneumonia. III. Pneumococcal carrier studies. Am. J. Hyg. 44: 207 230.
48. Horsefall, F. L.,, K. Goodner,, and C. M. MacLeod. 1938. Antipneumococcus rabbit serum as a therapeutic agent in lobar pneumonia. II. Additional observations in pneumococcus pneumonia of nine different types. N. Y. State J. Med. 38: 245 255.
49. Issaeff, B. 1893. Contribution à l’étude de l’immunité acquise contre le pneumocoque. Ann. Inst. Pasteur (Paris) 7: 260 279.
50. Klemperer, G.,, and F. Klemperer. 1891. Versuche über Immunisierung und Heilung bei der Pneumokokkeninfection. Berl. Klin. Wochenschr. 28: 833 835, 869 875.
51. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3: 171 196.
52. Knecht, J. C.,, G. Schiffman,, and R. Austrian. 1970. Some biological properties of pneumococcus type 37 and the chemistry of its capsular polysaccharide. J. Exp. Med. 132: 475 487.
53. Kruse, W.,, and S. Pansini. 1892. Untersuchungen über den Diplococcus pneumoniae und verwandte Streptokokken. Z. Hyg. Infektionskr. 11: 279 380.
54. Lister, F. S. 1916. An experimental study of prophylactic inoculation against pneumococcal infection in the rabbit and in man. S. Afr. Inst. Med. Res. No. 8: 231 287.
55. Loda, F. A.,, A. M. Collier,, W. P. Glezen,, K. Strangert,, W. A. Clyde, Jr.,, and F. W. Denny. 1975. Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J. Pediatr. 87: 1087 1093.
56. MacLean, I. H.,, K. B. Rogers,, and A. Fleming. 1939. M & B 693 and pneumococci. Lancet i: 562 568.
57. MacLeod, C. M.,, R. G. Hodges,, M. Heidelberger,, and W. G. Bernhard. 1945. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J. Exp. Med. 82: 445 465.
58. Marshall, E. K., Jr.,, K. Emerson, Jr.,, and W. C. Cutting. 1937. Para-aminobenzene sulfonamide; absorption and excretion; method of determination in urine and blood. JAMA 108: 953 957.
59. McCarty, M. 1946. Purification and properties of desoxyribonuclease isolated from beef pancreas. J. Gen. Physiol. 29: 123 139.
60. McCarty, M. 1985. The Transforming Principle. Discovering That Genes Are Made of DNA, p. 73 88. W. W. Norton & Co., New York, N.Y.
61. McCarty, M. 1985. The Transforming Principle. Discovering That Genes Are Made of DNA, p. 213 235. W. W. Norton & Co., New York, N.Y.
62. Metchnikoff, E. 1891. Etudes sur l’immunité. IV. L’immunité des cobayes vaccinées contre le Vibrio Metchnikowii. Ann. Inst. Pasteur (Paris) 5: 465 478.
63. Moore, H. F.,, and A. M. Chesney. 1917. A study of ethylhydrocuprein (optochin) in the treatment of acute lobar pneumonia. Arch. Intern. Med. 19: 611 682.
64. Moore, H. F.,, and A. M. Chesney. 1918. A further study of ethylhydrocuprein (optochin) in the treatment of acute lobar pneumonia. Arch. Intern. Med. 21: 659 681.
65. Morgenroth, J.,, and M. Kaufmann. 1912. Arzneifestigkeit bei Bakterien (Pneumokokken). Z. Immunitaetsforsch. Exp. Ther. 15: 610 624.
66. Morgenroth, J.,, and R. Levy. 1911. Chemotherapie der Pneumokokkeninfektion. Berl. Klin. Wochenschr. 48: 1560 1561, 1979-1983.
67.Netter. 1886. De l’endocardite végétante-ulcéreuse d’origine pneumonique. Arch. Physiol. Norm. Pathol. 8 [Ser. 3]: 106161.
68. Neufeld, F. 1900. Ueber eine specifische bacteriolytische Wirkung der Galle. Z. Hyg. Infektionskr. 34: 454 464.
69. Neufeld, F. 1902. Ueber die Agglutination der Pneumokokken und über die Theorieen der Agglutination. Z. Hyg. Infektionskr. 40: 54 72.
70. Neufeld, F.,, and R. Etinger-Tulczynska. 1932. Nasale Pneumokokkeninfectionen and Pneumokokkenkeimtrager im Tierversuch. Z. Hyg. Infektionskr. 112: 492 526.
71. Neufeld, F., and Händel. 1910. Weitere Untersuchungen über Pneumokokken Heilsera. III. Mitteilung. Über Vorkommenen und Bedeutung atypischer Varietäten des Pneumokokkus. Arb. Kaiserlichen Gesundheitsamte 34: 293 304.
72. Neufeld, F.,, and W. Levinthal. 1928. Beiträge zur Variabilität der Pneumokokken. Z. Immunitaetsforsch. Exp. Ther. 55: 324 340.
73. Neufeld, F.,, and W. Rimpau. 1904. Ueber die Antikörper des Streptokokken und Pneumokokken—Immunserums. Dtsch. Med. Wochenschr. 30: 1458 1460.
74. Novak, R.,, B. Henriques,, E. Charpentier,, S. Normark,, and E. Tuomanen. 1999. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 399: 590 593.
75. Osler, W. 1897. On certain features in the prognosis of pneumonia. Am. J. Med. Sci. 113: 1 10.
76.Pasteur. 1881. Note sur la maladie nouvelle provoquée par la salive d’un enfant mort de la rage. Bull. Acad. Med. (Paris) 10: 94103.
77. Rich, A. R.,, and C. M. McKee. 1939. The pathogenicity of avirulent pneumococci for animals deprived of leukocytes. Bull. Johns Hopkins Hosp. 64: 434 446.
78. Robbins, J. B.,, R. Schneerson,, P. Anderson,, and D. H. Smith. 1996. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. JAMA 276: 1181 1185.
79. Schiemann, O.,, and W. Casper. 1927. Sind die spezifisch präcipitablen Subtanzen der 3 Pneumokokkentypen Haptene? Z. Hyg. Infektionskr. 108: 220 257.
80. Schmidt, L. H.,, and C. L. Sessler. 1943. Development of resistance to penicillin by pneumococci. Proc. Soc. Exp. Biol. Med. 52: 353 357.
81. Shapiro, E. D.,, A. T. Berg,, R. Austrian,, D. Schroeder,, V. Parcells,, A. Margolis,, R. K. Adair,, and J. D. Clemens. 1991. The protective efficacy of pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325: 1453 1460.
82. Sternberg, G. M. 1881. A fatal form of septicaemia in the rabbit, produced by subcutaneous injection of human saliva. An experimental research. Natl. Board Health Bull. 2: 781 783.
83. Sternberg, G. M. 1882. A fatal form of septicaemia in the rabbit, produced by the subcutaneous injection of human saliva. Studies Biol. Lab. Johns Hopkins Univ. 2: 183 200.
84. Sternberg, G. M. 1882. Induced septicaemia in the rabbit. Am. J. Med. Sci. 84: 69 76.
85. Stryker, L. M. 1916. Variations in the pneumococcus induced by growth in immune serum. J. Exp. Med. 24: 49 68.
86. Tettelin, H.,, K. E. Nelson,, S. Peterson,, J. A. Eisen,, T. D. Read,, R. T. DeBoy,, D. H. Haft,, R. J. Dodson,, A. Scott Durkin,, M. Gwinn,, J. F. Kolonay,, W. C. Nelson,, J. D. Peterson,, L. A. Umayam,, O. White,, S. L. Salzberg,, M. R. Lewis,, D. Radune,, E. Holtzapple,, H. Khouri,, A. M. Wolf,, T. R. Utterback,, S. Angiuoli,, T. Dickinson,, E. K. Hickey,, I. E. Holt,, B. J. Loftus,, F. Yang,, H. O. Smith,, J. C. Venter,, B. A. Dougherty,, D. A. Morrison,, S. Hillingshead,, and C. M. Fraser. 2001. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293: 498 506.
87. Tillett, W. S.,, and T. Francis, Jr. 1930. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J. Exp. Med. 52: 561 571.
88. Tugendreich, J.,, and C. Russo. 1913. Ueber die Wirkung von Chinaalkaloiden auf Pneumokokkenkulturen. Z. Immunitaetsforsch. Exp. Ther. 19: 156 171.
89. Watson, J. D.,, and F. H. C. Crick. 1953. The structure of DNA. Cold Spring Harbor Symp. Quant. Biol. 18: 123 131.
90. Watson, J. D.,, M. Gilman,, J. Witkowski,, and M. Zoller. 1992. Recombinant DNA, 2nd ed. Scientific American Books, New York, N.Y.
91. Webster, L. T.,, and T. P. Hughes. 1931. The epidemiology of pneumococcus infection. J. Exp. Med. 53: 535 552.
92. Weiser, J. N.,, R. Austrian,, P. K. Sreenviasan,, and H. R. Masure. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasal colonization. Infect. Immun. 62: 2582 2589.
93. Welch, W. H. 1892. The micrococcus lanceolatus, with a special reference to the etiology of acute lobar pneumonia. Bull. Johns Hopkins Hosp. 3: 125 139.
94. White, B. 1938. The Biology of Pneumococcus, p. XVI XVII. The Commonwealth Fund, New York, N.Y.
95. Wright, A. E.,, W. Parry Morgan,, L. Colebrook,, and R. W. Dodgson. 1914. Observations on prophylactic inoculation against pneumococcus infections, and on the results which have been achieved by it. Lancet i: 1 10, 87 95.
96. Zighelboim, S.,, and A. Tomasz. 1980. Penicillin-binding proteins of multiply antibiotic resistant South African strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 17: 434 442.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error